Jci_page_head_homepage_01 Jci_page_head_homepage_02
Ann Marie LeVine, Jacquelyn A. Reed, Kim E. Kurak, Eli Cianciolo, Jeffrey A. Whitsett
Published in Volume 103, Issue 4
J Clin Invest. 1999; 103(4):563–569 doi:10.1172/JCI5212
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

Exogenous GM-CSF enhances GBS clearance from the lung. Concentration of GBS was determined by quantitative cultures of lung homogenates. Colony counts were significantly decreased 24 h after administration of 104 CFU GBS to wild-type mice (solid) treated with three doses of aerosolized recombinant mouse GM-CSF (4 ng/mouse) compared with untreated controls (hatched bars). Data are mean ± SEM with n = 15 mice per group. *P < 0.05 compared with untreated wild-type mice.